Porzio Life Sciences Co-Sponsors, Presents at CBI's 13th Annual Pharmaceutical Compliance Congress

The Ritz-Carlton, Washington, D.C.

Porzio, Bromberg & Newman attorneys and Porzio Life Sciences executives will speak at CBI's 13th Annual Pharmaceutical Compliance Congress, scheduled April 26 - 27, 2016 in Washington, D.C.

Chief Compliance Officer Summit, April 26, 2016 at 1:30 PM
Summit Host: John P. Oroho

"Data Aggregation - Challenges with Managing Cross-Border Spend," April 26, 2016 at 3:35 PM
Speakers: D. Jeffrey Campbell and Brian P. Sharkey

"Social Media - New Challenges and Opportunities," April 26, 2016 at 4:05 PM
Speakers: Jennifer A. Romanski and Vito A. Gagliardi, Jr.

"Data Analysis, Risk Mitigation and Predictive Analytics," April 27, 2016 at 10:30 AM
Track Chair: John P. Oroho

Attendees: Michelle D. Axelrod, Christine N. BradshawLaura C. ConwayNancy A. HenshawGiuliana L. Politano

Widely recognized as the most comprehensive, senior-level compliance meeting, CBI's esteemed Pharmaceutical Compliance Congress (PCC) attracts more than 400 industry leaders including dozens of CCOs.  PCC features first-hand feedback from government agencies including DOJ, FDA and U.S. Attorneys. 

Program Highlights: 

  • Dedicated, high-level content for senior-level professionals
  • Fundamental sessions tailored to those new to the compliance space
  • Pertinent, pressing issues facing compliance professionals including FCPA, considerations for BRIC nations, compliance for specialty products, third-party investigations
  • The industry's only CCO Summit
  • The Enforcement Panel

For more information, please click here.


Share with: